The findings indicate that WIP2W can bind specifically to the WT1 protein, inducing cell cycle arrest and notable cytotoxicity in WT1+ BP-CML cells. This evidence concerns the gene WT1 and chronic myelogenous leukemia, BCR-ABL1 positive.